Atlas Trials

Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis

Clinical trial NCT02110966 · COMPLETED

Trial details

NCT number
NCT02110966
Sponsor
Daniel Chavarría Bolaños
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Symptomatic Irreversible Pulpitis
Start date
2014-04-01
Primary completion
2014-10-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.